Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Corgenix Medical Corporation Stories

2010-09-23 08:15:00

DENVER, Sept. 23 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, today filed its fiscal year Form 10-K and reported financial results. The report disclosed that the company's operating results have advanced for the fiscal year ended June 30, 2010. Some of the results highlighted by the report are as follows: Adjusted EBITDA for the year was $815,981 vs. $403,741 for the prior year. Net income...

2010-09-14 08:15:00

DENVER, Sept. 14 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, September 23, 2010, at 4:00 PM EDT to discuss the Company's financial and operating performance for its fiscal year ended June 30, 2010, and the status of the Company's product development and marketing activities. Corgenix invites all those interested in hearing management's discussion of...

2010-07-19 08:15:00

DENVER and PARIS, July 19 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and the ELITech Group, a Paris, France-based, privately held group of companies and worldwide manufacturer and distributor of in-vitro diagnostic equipment and reagents, today announced a broad strategic alliance. Terms of the agreement include: Strategic Investment - ELITech will initially purchase 8,333,334 shares of...

2010-07-16 08:29:00

DENVER, July 16 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Wednesday, July 21, 2010, at 4:00 PM EDT to discuss the Company's announced major collaboration and investment from the ELITech Group, a Paris, France-based, privately held group of companies and worldwide manufacturer and distributor of in-vitro diagnostic equipment and reagents. The Form 8-K related...

2010-06-24 08:15:00

DENVER, June 24 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, has been issued an additional U.S. patent covering its AspirinWorks® technology and product line. The patent, issued June 1, 2010, covers the AspirinWorks Test and represents the latest addition to Corgenix intellectual property (IP) portfolio. AspirinWorks is the only FDA-cleared test that measures the urinary...

2010-06-22 08:15:00

DENVER, June 22 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS). "We are very pleased to announce these two very important accomplishments," said...

2010-06-15 11:15:00

DENVER, June 15 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, has announced it will be exhibiting its AspirinWorks® Test June 17-19 at the Pri-Med New York 2010 conference. The meeting will take place at the Jacob K. Javits Convention Center in New York, N.Y. Corgenix representatives will be on-hand during the conference at booth No. 700 to answer questions about the...

2010-05-13 08:15:00

DENVER, May 13 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, today filed its 3rd quarter Form 10-Q and reported its financial results. The report disclosed that the company's revenues showed an 8.1% increase for the quarter and a 2.8% increase for the nine months ended March 31, 2010, in addition to a marked turnaround in the bottom line results. Some of the results highlighted by the report...

2010-05-04 08:15:00

DENVER, May 4 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, May 13, 2010, at 4:00 PM EDT to discuss the Company's financial and operating performance for the third quarter ended March 31, 2010, and the status of the Company's product development and marketing activities. Corgenix invites all those interested in hearing management's discussion of the...

2010-04-13 08:15:00

DENVER, April 13 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, including innovative products for emerging pathogens and lethal viruses, today announced a major extension of the collaborative effort to combat important viral diseases. The National Institutes of Health (NIH) has awarded a grant totaling $600,000 to Corgenix for the two-year study, which will focus on development of novel,...